Today, Creative Biolabs, a global company pioneering new biotechnologies, released a customized and standardized CAR-T in vivo assay, aiming to provide a high-quality and reliable one-stop service for clients across the world.
As a new star treatment expected to fight against cancer effectively, CAR-T therapy has attracted much attention from academics, doctors, patients, and investors worldwide. However, there still remain several potential risks posed for CAR-T cell clinical application, such as cytokine storm. Therefore, preclinical in vivo assessment of the efficacy and safety of CAR-T cells are essential for dosage determination and risk managements for this promising immunotherapy against cancers.
“ Our one-stop service covers all aspects from cell biology to animal tests. And we attach great importance to the construction of tumor xenograft animal models. In order to improve CAR-T development, different robust animal models and assay systems have been used in-house. It will help you save time and budget. ” said Dr. Monika Müller, Scientific Officer of Creative Biolabs.
“ We perform CAR-T cell preclinical in vivo animal testing in xenograft murine models derived from well-defined cell lines or primary human tumor cells. And immunodeficient mice without effective innate immunity become the best choice for tumor cells engraftment and CAR-T cells evaluation”
With a high-quality platform and professional team, Creative Biolabs promised that their essays are compliant with Good Laboratory Practice (GLP), which is essential for IND application. And their experienced scientists will assist clients in designing the research program that best suits their purpose and advance their CAR-T cell therapy through clinical trials.
About Creative Biolabs
As a global company, Creative Biolabs have more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, we are the established leading expert in TCR and CAR T&NK cell immune therapy development, as we offer the one-stop custom services that cover the entire new drug development pipeline. Additionally, we also offer an exclusive line of ready-to-use TCR and CAR T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, we have built up a unique unparalleled CAR construction and production platform for all four CAR generations.
Media Contact
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: http://www.creativebiolabs.net
Source: www.abnewswire.com
